Technology News and Research

RSS

Boston Scientific initiates study to compare PROMUS Element Stent to XIENCE PRIME Stent System

Boston Scientific Corporation today announced the initiation of the PLATINUM PLUS clinical trial, an investigator-sponsored research (ISR) study designed to compare the performance of the PROMUS® Element™ Everolimus-Eluting Coronary Stent System to the XIENCE PRIME™ Everolimus-Eluting Coronary Stent System.

26 May 2010

Accenture announces enhanced insurance industry solutions

Accenture has unveiled newly enhanced claims and policy administration solutions designed to help property and casualty (P&C) and life insurers focus on operational efficiency and profitable growth by enhancing process automation and multi-channel distribution integration.

26 May 2010

KCI to feature expanded line of NPTP products and services at EWMA congress

Kinetic Concepts, Inc. today announced the company will feature its expanded line of negative pressure technology platform products and services at the annual European Wound Management Association congress in Geneva, Switzerland. Highlighting the company's commitment to innovative therapies, the new product line will improve the portability and adoption of V.A.C. Therapy, while further specializing the clinical application of negative pressure.

26 May 2010

Federal funding to support health IT training; New web tools for patients

A federally-funded health information training program is now underway, Modern Healthcare reports. "Last month, HHS' Office of the National Coordinator for Health Information Technology awarded $112 million of stimulus funds to dozens of universities and community colleges.

26 May 2010

Trintech first-quarter revenues up 9% to $8.5 million

Trintech Group Plc, a leading provider of integrated financial governance, risk management and compliance (GRC) solutions for commercial, financial and healthcare markets, today announced its first quarter 2011 financial results. Following the sale of its healthcare business to The Advisory Board Company on April 1, 2010, Trintech is required to present its financial results on a continuing and discontinued basis.

26 May 2010

QIAGEN acquires rights to 70 molecular food safety tests developed by Institute for Product Quality

QIAGEN today announced that it has entered into an agreement with the Institute for Product Quality (ifp), pursuant to which QIAGEN has acquired all rights to 70 molecular food safety tests developed by the Berlin-based specialized laboratory center for food analysis.

From QIAGEN Manchester Limited 26 May 2010

Heptares Therapeutics, O2h extend multi-FTE -synthetic chemistry services collaboration

Executives from Heptares Therapeutics (Welwyn Garden City, UK) and O2h (Cambridge, UK) announced today an extension of the agreement under which O2h provides multi-FTE -synthetic chemistry services to support discovery programmes at Heptares.

26 May 2010

Benefit Advocates launches its redesigned website

Benefit Advocates Inc. recently launched its redesigned website at www.benefitadvocates.net. The new design offers visitors ease of use and comprehensive information on Benefit Advocates' company profile, employer and broker services, and healthcare industry perspectives.

26 May 2010

St. Jude Medical initiates enrollment in FAME II trial for coronary artery disease

St. Jude Medical, Inc., a global medical device company, announced today at EuroPCR that the first patient was enrolled in the FAME II (Fractional Flow Reserve (FFR)-Guided Percutaneous Coronary Intervention Plus Optimal Medical Treatment vs. Optimal Medical Treatment Alone in Patients with Stable Coronary Artery Disease) trial.

25 May 2010

Bayer selects Vision Chain as Enterprise Demand Signal Repository and Predictive Analytics platform

Vision Chain, Inc., the leading global provider of demand signal repository and predictive analytic solutions, announced today that Bayer Healthcare LLC, the global leader in trusted brands for healthcare and nutrition, has licensed its technology platform to analyze store-specific sales, assortments, prices, promotions and other factors to optimize go-to-market efforts with multiple retailers.

25 May 2010

Halfpenny Technologies releases new critical value alerting, reporting feature for ITF-GoDoc solution

Halfpenny Technologies, Inc., a leading health information exchange (HIE) solutions provider specializing in laboratory, pathology and physician electronic medical record (EMR) system interoperability, has introduced a new critical value alerting and reporting feature for its ITF-GoDoc solution. ITF-GoDoc enables physicians to securely access laboratory, pathology and radiology result reports from their iPhone, Droid or Blackberry Storm-powered smartphones.

25 May 2010

Applied Spine Technologies awarded U.S. patents for 'Dynamic Spine Stabilizer' and 'Spring Junction'

Applied Spine Technologies, Inc., a medical device company focused on motion preservation of the lumbar spine, was awarded two new patents by the U.S. Patent and Trademark Office on May 11, 2010.

25 May 2010

YesDTC acquires DRTV marketing rights to patented MediPendant medical alarm device

YesDTC Holdings, Inc., a direct-to-consumer global distributor and marketer of consumer goods and products, announced today, the Company has acquired the rights to market the patented MediPendant™ medical alarm device from Medical Alarm Concepts Holding, Inc. via direct response television (DRTV).

25 May 2010

Exactech acquires Brighton Partners

Exactech, Inc., a developer and producer of bone and joint restoration products for hip, knee, shoulder, spine and biologic materials, announced today that the company has acquired Brighton Partners, Inc., the sole source supplier of the direct compression molded polyethylene bearings used exclusively in Exactech's flagship product, the Optetrak® knee replacement system.

25 May 2010

T2 Biosystems raises $15 million to accelerate development of next generation diagnostic platform

T2 Biosystems, Inc., a company developing the first decentralized clinical diagnostic solution that eliminates extensive sample preparation and enables rapid molecular and immunodiagnostic testing on a single instrument, today announced that it has raised approximately $15 million in a Series C financing. Proceeds from the financing will be used to accelerate the development and commercialization of T2 Biosystems' next generation diagnostic platform for use in the decentralized setting.

25 May 2010

CoDa Therapeutics reports positive results from Phase 2 study of NEXAGON for chronic venous leg ulcers

CoDa Therapeutics, Inc., a biopharmaceutical company focused on the development and commercialization of therapeutics for wound care and tissue repair, today announced positive results from its Phase 2 NOVEL Study of NEXAGON® in patients with chronic venous leg ulcers. NEXAGON® is a topically applied, novel therapeutic candidate, with the potential to revolutionize the wound healing treatment paradigm by leveraging a new mechanism and target involved in the healing process.

25 May 2010

VentureMD closes on fund to incubate promising medical device technologies into successful companies

VentureMD, a seed stage medical device business accelerator, has closed on a fund to incubate promising medical device technologies into successful companies.

25 May 2010

Significant progress on international development strategy for stem cell-derived human corneal tissue

International Stem Cell Corporation, www.intlstemcell.com, today announced significant progress on its international development strategy for stem cell-derived human corneal tissue. Such tissue can potentially be used to replace cadaver-derived corneas in treatment of severe corneal vision impairment and to eliminate the need to use live animals in safety testing of drugs, chemicals and consumer products.

25 May 2010

Sonomax Technologies signs collaboration agreement with DEC

Sonomax Technologies Inc. is pleased to announce that is has signed a collaboration agreement with the Dynamic Ear Company. DEC is a leading manufacturer and developer of innovative in-ear products that permit users to control the volume of external sound that reaches their ears, which by doing so, contribute to hearing safety and a comfortable sound experience.

25 May 2010

Yissum introduces Dralgo platform to accelerate discovery of promising drug candidates

Drug discovery and development is a highly risky process, with only one in 10,000 initial candidate compounds reaching the market. When taking into account the aborted candidates, the cost of developing one successful drug may even reach $1 billion, and the development process may take as long as 15-20 years.

25 May 2010

Technology News and Research

Boston Scientific initiates study to compare PROMUS Element Stent to XIENCE PRIME Stent System

Accenture announces enhanced insurance industry solutions

KCI to feature expanded line of NPTP products and services at EWMA congress

Federal funding to support health IT training; New web tools for patients

Trintech first-quarter revenues up 9% to $8.5 million

QIAGEN acquires rights to 70 molecular food safety tests developed by Institute for Product Quality

Heptares Therapeutics, O2h extend multi-FTE -synthetic chemistry services collaboration

Benefit Advocates launches its redesigned website

St. Jude Medical initiates enrollment in FAME II trial for coronary artery disease

Bayer selects Vision Chain as Enterprise Demand Signal Repository and Predictive Analytics platform

Halfpenny Technologies releases new critical value alerting, reporting feature for ITF-GoDoc solution

Applied Spine Technologies awarded U.S. patents for 'Dynamic Spine Stabilizer' and 'Spring Junction'

YesDTC acquires DRTV marketing rights to patented MediPendant medical alarm device

Exactech acquires Brighton Partners

T2 Biosystems raises $15 million to accelerate development of next generation diagnostic platform

CoDa Therapeutics reports positive results from Phase 2 study of NEXAGON for chronic venous leg ulcers

VentureMD closes on fund to incubate promising medical device technologies into successful companies

Significant progress on international development strategy for stem cell-derived human corneal tissue

Sonomax Technologies signs collaboration agreement with DEC

Yissum introduces Dralgo platform to accelerate discovery of promising drug candidates

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News